Encompass Health Corporation (NYSE:EHC) Q1 2023 Earnings Conference Call April 28, 2023 10:00 AM ET Company Participants Mark Miller - IR Mark Tarr - President & CEO Doug Coltharp - CFO Conference Call Participants Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Andrew Mok - UBS Ben Hendrix - RBC Capital Markets Brian Tanquilut - Jefferies Ann Hynes - Mizuho Securities Operator Good morning, everyone, and welcome to Encompass Health's First Quarter 2023 Earnings C ...

Hospital Operations and Growth - In 2022, the company operated 153 hospitals, an increase from 145 in 2021 and 137 in 2020, with discharges rising to 211,116 from 197,639 in 2021[26] - The company has increased its number of licensed beds by approximately 56% since 2012, adding around 3,700 beds, and plans to open 8 new hospitals and add 80 to 100 beds to existing hospitals in 2023[35][36] - Approximately 6% of stroke recovery patients in the U.S. were treated at the company's hospitals in 2022, accounting for about 19% of the overall patient mix[39] Financial Performance - Net operating revenues for inpatient services reached $4,251.6 million in 2022, up from $3,918.0 million in 2021, while total revenues increased to $4,348.6 million from $4,014.9 million[26] - Revenues from Medicare and Medicare Advantage represent approximately 80% of total revenues, highlighting the significance of government payments to operations[59] - In 2022, Medicare accounted for 65.3% of the company's total revenue, a slight increase from 64.4% in 2021[60] Medicare and Reimbursement - Medicare Advantage payors represented 15.1% of net operating revenues in 2022, up from 8.4% in 2017, with reimbursement based on case mix group increasing from 58% to 88% during the same period[37] - The company must comply with Medicare rules, including the "60% Rule," which requires at least 60% of patients to have specific qualifying diagnoses[69] - Future changes to Medicare reimbursement rates could materially affect the company's financial position and operations[65] Compliance and Regulatory Environment - The company is subject to significant federal, state, and local regulations that affect reimbursement for services provided[81] - The federal False Claims Act imposes penalties for knowingly presenting false claims, with potential damages equal to three times the overpayment plus up to $25,000 per claim[94] - Compliance with extensive healthcare regulations requires substantial time and expense, and failure to comply could result in significant penalties or operational changes[180] Employee Management and Development - The total employee count as of December 31, 2022, was approximately 35,000, with 20,839 full-time employees, 2,559 part-time employees, and 11,121 pool/per-diem employees[44] - The company reimbursed over $1.2 million in tuition and paid over $2.8 million toward employees' student loan debt in 2022, supporting employee education[52] - The company has invested in technology for on-demand learning and development programs, enhancing employee development opportunities[53] Patient Care and Services - The company aims to enhance patient care through post-acute solutions, leveraging electronic medical record technologies and strategic partnerships[40] - As of December 31, 2022, the company had installed onsite hemodialysis systems in 41 hospitals, improving patient satisfaction and reducing treatment costs[42] - The average age of Medicare patients is approximately 76, with the population aged 75 to 79 expected to grow at about 5% per year through 2026, indicating a rising demand for rehabilitation services[34] Financial Risks and Challenges - The company is experiencing a shift in payor mix from traditional Medicare to Medicare Advantage, which generally results in lower reimbursement rates and potentially higher bad debt[153] - The company has faced challenges related to compliance with Medicare enrollment requirements, with potential terminations from the Medicare program posing a material risk to its financial position[201] - The company is subject to various audits that may challenge the medical necessity of treatments, affecting Medicare claims[139] Cybersecurity and Data Privacy - The company has implemented extensive security measures to protect patient data, but remains vulnerable to cyber threats, which could lead to significant financial and reputational damage[216] - The potential for security breaches involving electronic health data is heightened, which could lead to significant liabilities and reputational harm[196] - Noncompliance with electronic health data regulations could result in civil monetary penalties and exclusion from federal health care programs, adversely affecting the company's operations[195] Market and Competitive Landscape - The company is the largest operator of inpatient rehabilitation hospitals in the U.S., but faces intense competition from acute-care hospitals and other healthcare providers[221] - Approximately 91% of the company's hospital referrals come from acute-care hospitals, making it susceptible to competition from those expanding into post-acute rehabilitation services[221] - Changes in state laws regarding certificate of need (CON) could increase competition, affecting the company's ability to expand operations in certain states[224]

Encompass Health Corporation [EHC] Q4 2022 Earnings Conference Call February 7, 2023 10:00 AM ET Company Participants Mark Tarr - President & CEO Doug Coltharp - CFO Mark Miller - IR Conference Call Participants Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Andrew Mok - UBS Ben Hendrix - RBC Capital Markets Brian Tanquilut - Jefferies Matt Larew - William Blair Ann Hynes - Mizuho Securities Operator Good morning, everyone, and welcome to Encompass Health's fourt ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share EHC New York Stock Exchange FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Num ...

Encompass Health Corporation (NYSE:EHC) Q3 2022 Results Conference Call October 27, 2022 10:00 AM ET Company Participants Mark Miller - Chief IR Officer Mark Tarr - President and CEO Doug Coltharp - CFO Conference Call Participants Kevin Fischbeck - Bank of America Pito Chickering - Deutsche Bank Ben Hendrix - RBC Capital Markets Matt Larew - William Blair Sarah James - Barclays Operator Good morning, everyone, and welcome to Encompass Health's Third Quarter 2022 Earnings Conference Call. [Operator Instruct ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share EHC New York Stock Exchange FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0 ...

Encompass Health Corporation (NYSE:EHC) Q2 2022 Earnings Conference Call August 2, 2022 10:00 AM ET Company Participants Mark Miller - Chief IR Officer Mark Tarr - President and CEO Doug Coltharp - CFO Patrick Darby - General Counsel and Corporate Secretary Conference Call Participants Andrew Mok - UBS Joanna Gajuk - Bank of America Brian Tanquilut - Jefferies John Ransom - Raymond James Pito Chickering - Deutsche Bank Matthew Borsch - BMO Capital Markets Sarah James - Barclays Operator Good morning, everyo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share EHC New York Stock Exchange FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number ...

Encompass Health Corporation (NYSE:EHC) Q1 2022 Earnings Conference Call April 28, 2022 10:00 AM ET Company Participants Mark Miller – Chief Investor Relations Officer & Senior Vice President, Investor Relations Mark Tarr – President and Chief Executive Officer Doug Coltharp – Chief Financial Officer Barb Jacobsmeyer – Chief Executive Officer-Home Health and Hospice Conference Call Participants Kevin Fischbeck – Bank of America A.J. Rice – Credit Suisse Sarah James – Barclays Matt Larew – William Blair Andr ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _________________________________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 ________________________________________________________ Encompass Health Corporation (Exact Name of Registrant as Specified in its ...